Butler Hospital, Memory and Aging Program

Running trials

• Enrolling by invitation

  Alzheimer's Tau Platform: Regimen A - AADvac1

  NCT07167966· Phase 2· Source

• Recruiting

  Alzheimer's Tau Platform: Master Protocol

  NCT06957418· Phase 2· Source

• Enrolling by invitation

  Alzheimer's Plasma Extension

  NCT06416072· Source

• Enrolling by invitation

  BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers

  NCT05457998· Source

• Enrolling by invitation

  Alzheimer's Disease Neuroimaging Initiative 4

  NCT05617014· Source

• Active, not recruiting

  AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

  NCT04468659· Phase 3· Source

• Active, not recruiting

  A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

  NCT03887455· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease5 recruiting
• Frontotemporal dementia2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  TRC-PAD Program: In-Clinic Trial-Ready Cohort

  NCT04004767· Source

• Completed

  Alzheimer's Disease Neuroimaging Initiative 3

  NCT02854033· Source